AqueSys, Inc Information

AqueSys, Inc. is the first ophthalmic device company to focus exclusively on the treatment of glaucoma by re-envisioning sub-conjunctival outflow with a minimally invasive stent for the reduction of intraocular pressure. Backed by more than a decade of research and recent commercialization in European markets, the safety and efficacy of the company’s proprietary technology supports glaucoma surgeons and patients in the management of intraocular pressure to arrest the progression of vision loss associated with glaucoma. Privately held and headquartered in Southern California, AqueSys is working to change the treatment of glaucoma to benefit patients, physicians and payors around the world through the research, development, manufacturing and commercialization of its minimally invasive glaucoma stents. Additional information about the XEN Gel Stent can be found at www.aquesys.com.

Website	https://www.aquesys.com
Revenue	$1 million
Funding	$90.6 million
Employees	4 (0 on RocketReach)
Founded	2006
Address	26970 Aliso Viejo Pkwy, Aliso Viejo, California 92656, US
Phone	+1 949-450-0250
Fax	(949) 450-0249
Technologies	JavaScript , HTML , Bootstrap +4 more (view full list)
Industry	Medical Devices, Medical Devices & Equipment, Medical Device, Ophthalmology, Manufacturing, Retail, Health Care, Glaucoma
Keywords	Glaucoma Treatment, Ophthalmic Devices, Eye Surgery, Glaucoma Surgery, Ocular Hypertension, Medical Devices, Ophthalmology, Pressure Regulation, Fluid Dynamics, Ocular Implants, Surgical Devices, Eye Care, Medical Technology, Vision Care, Healthcare Technology
Competitors	Johnson & Johnson, Medtronic, Abbott, Stryker, Alcon, ZEISS Group, Bausch + Lomb, CooperVision, Hoya Electronics, Rayner +44 more (view full list)
SIC	SIC Code 50 Companies, SIC Code 504 Companies
NAICS	NAICS Code 42 Companies, NAICS Code 423 Companies